Berkadia Medical & Life Sciences is proud to exclusively present the Texas Oncology – Amarillo Cancer Center, (the “Property”), a trophy-quality, Class A, comprehensive cancer treatment facility encompassing 51,038 rentable square feet. Situated in Amarillo, Texas, the newly constructed facility offers investors a unique opportunity to acquire a state-of-the-art center 100% leased to Physician Reliance, LLC, dba Texas Oncology. Physician Reliance, LLC is a subsidiary of US Oncology which is a wholly owned subsidiary of McKesson Corporation (Moody’s ‘A3’). Texas Oncology is a premier physician-led oncology practice with over 550 physicians and 300 locations across Texas and Oklahoma. The lease features over 17 years of remaining term, inclusive of renewal options, with 2.50% annual rent escalations, ensuring secure, long-term cash flow growth and exceptional income stability for future ownership.

Completed in 2023, this purpose-built facility provides a comprehensive range of oncology services, featuring 20 clinical exam rooms, four surgical suites, two linear accelerator vaults, 30 infusion chairs, imaging and recovery suites, clinical trial space, lab, and an on-site pharmacy. The tenant has invested $13 million into the buildout of the Property above the tenant improvement allowance provided by the Landlord, demonstrating its commitment to the location.

The Property offers investors the opportunity to acquire a Class A, mission-critical cancer center with long-term, growing income from an investment-grade credit healthcare provider. In addition, given its recent construction and triple-net lease structure, an incoming buyer will benefit from minimal operating responsibilities or capital requirements. The Property is offered fee simple and free & clear of existing debt.